Dental imaging technology company Calcivis is setting its sights on US growth after having secured pre-market approval from the US Food and Drug Administration (FDA).
As the first Scottish medical device to secure the coveted accreditation, the Calcivis Imaging System aims to revolutionise the dental sector by enabling the move to a more preventive treatment model.
The approval is only awarded after a statutory process of scientific review to ensure the efficacy and safety of medical devices and it should now allow the Edinburgh-based business to tap into the multi-billion dollar US dental market.
